# Defilade Capital Management, L.P. 13F Q2 2026: $747 million

Defilade Capital Management, L.P. reported $747 million in 13F securities across 39 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Eli Lilly & Co at $46.9 million, 6.3% of the reported value. Since Q1 2026 it opened 20 new positions and exited 12.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $746,947,371
- Positions: 39
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 2088557
- Form 13F file number: 028-26338
- CRD number: 337997
- Business address: 6001 Shellmound St Suite 625, Emeryville, CA 94608
- SEC filing: [0002088557-26-000008](https://www.sec.gov/Archives/edgar/data/2088557/000208855726000008/0002088557-26-000008-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/defilade-capital-management-l-p-337997)

## Top 25 holdings by value

The largest of 39 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 39,086 | $46.9 million | +18,390 |
| [Pfizer Inc](https://specstream.ai/data/institutional-holders/pfizer-inc-717081103) | COM | 1,771,743 | $42.7 million | +307,614 |
| [Veeva Sys Inc](https://specstream.ai/data/institutional-holders/veeva-sys-inc-922475108) | CL A COM | 236,709 | $42 million | New |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 682,005 | $39 million | New |
| [PTC Therapeutics Inc](https://specstream.ai/data/institutional-holders/ptc-therapeutics-inc-69366j200) | COM | 433,699 | $35.4 million | +57,534 |
| [Baxter Intl Inc](https://specstream.ai/data/institutional-holders/baxter-intl-inc-071813109) | COM | 1,459,380 | $31.1 million | New |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 281,838 | $30 million | +86,929 |
| [Zimmer Biomet Holdings Inc](https://specstream.ai/data/institutional-holders/zimmer-biomet-holdings-inc-98956p102) | COM | 317,426 | $27.3 million | -261,735 |
| [Insulet Corp](https://specstream.ai/data/institutional-holders/insulet-corp-45784p101) | COM | 176,932 | $26.9 million | New |
| [Thermo Fisher Scientific Inc](https://specstream.ai/data/institutional-holders/thermo-fisher-scientific-inc-883556102) | COM | 51,934 | $26 million | New |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 285,778 | $25.9 million | New |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 94,843 | $25.3 million | New |
| [Solventum Corp](https://specstream.ai/data/institutional-holders/solventum-corp-83444m101) | COM SHS | 316,454 | $24.4 million | New |
| [Medtronic PLC](https://specstream.ai/data/institutional-holders/medtronic-plc-g5960l103) | SHS | 303,301 | $23.7 million | New |
| [Elanco Animal Health Inc](https://specstream.ai/data/institutional-holders/elanco-animal-health-inc-28414h103) | COM | 864,080 | $21.3 million | -67,041 |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 546,848 | $20.3 million | New |
| [Envista Holdings Corporation](https://specstream.ai/data/institutional-holders/envista-holdings-corporation-29415f104) | COM | 726,108 | $19.1 million | New |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 82,827 | $15.5 million | -233,145 |
| [Icu Med Inc](https://specstream.ai/data/institutional-holders/icu-med-inc-44930g107) | COM | 105,700 | $15.5 million | -148,591 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 393,441 | $15.2 million | +40,851 |
| [Lantheus Hldgs Inc](https://specstream.ai/data/institutional-holders/lantheus-hldgs-inc-516544103) | COM | 132,662 | $14.7 million | -116,739 |
| [Ocular Therapeutix Inc](https://specstream.ai/data/institutional-holders/ocular-therapeutix-inc-67576a100) | COM | 1,490,286 | $14.6 million | +2,641 |
| [Eledon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/eledon-pharmaceuticals-inc-28617k101) | COM | 3,525,338 | $13.9 million | -38,789 |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 376,870 | $12 million | New |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 924,758 | $11.6 million | -579,778 |

## New positions in Q2 2026

20 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Veeva Sys Inc](https://specstream.ai/data/institutional-holders/veeva-sys-inc-922475108) | CL A COM | 236,709 | $42 million |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 682,005 | $39 million |
| [Baxter Intl Inc](https://specstream.ai/data/institutional-holders/baxter-intl-inc-071813109) | COM | 1,459,380 | $31.1 million |
| [Insulet Corp](https://specstream.ai/data/institutional-holders/insulet-corp-45784p101) | COM | 176,932 | $26.9 million |
| [Thermo Fisher Scientific Inc](https://specstream.ai/data/institutional-holders/thermo-fisher-scientific-inc-883556102) | COM | 51,934 | $26 million |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 285,778 | $25.9 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 94,843 | $25.3 million |
| [Solventum Corp](https://specstream.ai/data/institutional-holders/solventum-corp-83444m101) | COM SHS | 316,454 | $24.4 million |
| [Medtronic PLC](https://specstream.ai/data/institutional-holders/medtronic-plc-g5960l103) | SHS | 303,301 | $23.7 million |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 546,848 | $20.3 million |
| [Envista Holdings Corporation](https://specstream.ai/data/institutional-holders/envista-holdings-corporation-29415f104) | COM | 726,108 | $19.1 million |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 376,870 | $12 million |
| [Larimar Therapeutics Inc](https://specstream.ai/data/institutional-holders/larimar-therapeutics-inc-517125100) | COM | 3,670,135 | $11.2 million |
| [Enovis Corporation](https://specstream.ai/data/institutional-holders/enovis-corporation-194014502) | COM | 531,945 | $11 million |
| [Teleflex Incorporated](https://specstream.ai/data/institutional-holders/teleflex-incorporated-879369106) | COM | 80,118 | $10.2 million |
| [Glaukos Corp](https://specstream.ai/data/institutional-holders/glaukos-corp-377322102) | COM | 66,519 | $9.3 million |
| [Staar Surgical Co](https://specstream.ai/data/institutional-holders/staar-surgical-co-852312305) | COM PAR $0.01 | 322,126 | $9.2 million |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 239,440 | $9 million |
| [Livanova PLC](https://specstream.ai/data/institutional-holders/livanova-plc-g5509l101) | SHS | 107,373 | $8.8 million |
| [Black Diamond Therapeutics I](https://specstream.ai/data/institutional-holders/black-diamond-therapeutics-i-09203e105) | COM | 1,674,999 | $3.1 million |

## Positions exited in Q2 2026

12 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Schein Henry Inc](https://specstream.ai/data/institutional-holders/schein-henry-inc-806407102) | COM | 624,037 | $46 million |
| [Becton Dickinson & Co](https://specstream.ai/data/institutional-holders/becton-dickinson-co-075887109) | COM | 279,210 | $43.9 million |
| [Dexcom Inc](https://specstream.ai/data/institutional-holders/dexcom-inc-252131107) | COM | 538,762 | $33.8 million |
| [Intuitive Surgical Inc](https://specstream.ai/data/institutional-holders/intuitive-surgical-inc-46120e602) | COM NEW | 67,681 | $31.2 million |
| [Neurocrine Biosciences Inc](https://specstream.ai/data/institutional-holders/neurocrine-biosciences-inc-64125c109) | COM | 209,932 | $27.7 million |
| [Integer Hldgs Corp](https://specstream.ai/data/institutional-holders/integer-hldgs-corp-45826h109) | COM | 213,027 | $18.7 million |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 96,289 | $17.7 million |
| [Tandem Diabetes Care Inc](https://specstream.ai/data/institutional-holders/tandem-diabetes-care-inc-875372203) | COM NEW | 761,905 | $14.6 million |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 129,950 | $13.3 million |
| Ascendis Pharma A/S | SPONSORED ADR | 51,895 | $11.9 million |
| [Align Technology Inc](https://specstream.ai/data/institutional-holders/align-technology-inc-016255101) | COM | 67,332 | $11.5 million |
| [Biohaven LTD](https://specstream.ai/data/institutional-holders/biohaven-ltd-g1110e107) | COM | 315,944 | $2.7 million |

## Also on SpecStream

- [Defilade Capital Management, L.P. Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/2088557/000208855726000008/0002088557-26-000008-index.htm)
- [Defilade Capital Management, L.P. investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/defilade-capital-management-l-p-337997)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in and around Emeryville, California

- [Biotechnology companies in Emeryville, California](https://specstream.ai/data/businesses/biotechnology-companies/emeryville-california-united-states)
- [Software development companies in Emeryville, California](https://specstream.ai/data/businesses/software-development-companies/emeryville-california-united-states)
- [Child care centers in California, United States](https://specstream.ai/data/businesses/child-care-centers/california-united-states)
- [Insulation contractors in California, United States](https://specstream.ai/data/businesses/insulation-contractors/california-united-states)
- [Rubber and plastics manufacturers in California, United States](https://specstream.ai/data/businesses/rubber-and-plastics-manufacturers/california-united-states)
- [Boat and ship manufacturers in California, United States](https://specstream.ai/data/businesses/boat-and-ship-manufacturers/california-united-states)
